Discover how automation enhances accuracy and efficiency of liquid biopsy workflows, paving the way for advancements in personalized medicine and improved patient care
Mag-Bind Endo-Free Plasmid Mini & Midi Kits were unveiled at SLAS2025 International Conference & Exhibition
The Mag-Bind cfDNA LSP Kit was showcased at SLAS2025 International Conference & Exhibition in San Diego, California
Bio-Rad leads investment to support the launch of ColoSense® to advance diagnostic innovations for inflammatory bowel disease
A nucleic acid delivery solution to advance life science research and genetic medicines
This new development will allow mRNA therapies to be manufactured in Poland for drug developers to treat COVID, potential forms of cancer, and more
Promega and QuantumCyte sign co-marketing agreement aimed at enhancing the workflow solutions available to clinical laboratories
Waters has introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify sequence and modification confirmation of large molecule RNA therapeutics using liquid chromatography-mass spectrometry (LC-MS) analysis
Discover how Beckman Coulter Life Sciences is advancing synthetic biology research to tackle the challenges of our growing population
Biotium CELLDATA DNAstorm and RNAstorm 2.0 MagBead FFPE Kits for DNA and RNA extraction allow for greater streamlined automation
For fast and reliable RNA extraction without phenol/chloroform
Dr. Priya Chockalingam discusses the complexities of cell and gene therapies and how single-cell multimodal analysis can efficiently characterize gene-edited products
Find out how a pioneering biotech firm is revolutionizing drug discovery by integrating cutting-edge technologies, such as DNA-encoded library screening and state-of-the-art automation platforms
The vaccine quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor
In the fast-paced world of science, knowledge drives progress, and The Bio-Rad Academy leads the charge
Ribbon Bio Co-founder, Wladimir Labeikovsky, provides unique perspectives on synthetic DNA and discusses the company’s commitment to producing pure and accurate synthetic DNA molecules
Discover the latest technology to supercharge your gene therapy vector analysis workflow
Study shows blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90%
Authors successfully demonstrate transport of new-gene editing technology to ‘cut out’ HIV DNA from infected cells
Viral vector experts share AAV-based gene therapy manufacturing challenges and solutions
The collaboration delivers a walk-away solution suitable for high-throughput long-read sequencing in under two hours
Discover a novel non-viral gene delivery system that could transform cell and gene therapy workflows
Discover how the Wellcome Sanger Institute is helping to develop a physical atlas of all human organs
Explore how the latest advancements and recent regulatory approvals are making truly personalized medicine a reality
Companies unite in shared vision of enabling researchers to translate genomic insights
